Wexford Capital’s Firefly Neuroscience AIFF Stock Holding History

Wexford Capital’s Portfolio AIFF Stock Details AIFF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-961	Closed	-$2.92K	–	264
2024 Q3	$2.92K	Buy	+961	New	+$5.04K	﹤0.01%	165

Other funds holding AIFF

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WPW

Waldron Private Wealth Bridgeville, Pennsylvania $2.89B AUM 23.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wexford Capital's AIFF Position: Q4 2024 in Review

Wexford Capital sold out of Firefly Neuroscience (AIFF) in Q4 2024, closing a stake of 961 shares — an estimated $2.92K sold.

Wexford Capital first reported a position in AIFF in Q3 2024 and held it in 1 quarter. The position peaked at $2.92K in Q3 2024. 12 funds tracked by Wall St. Rank hold AIFF as of Q4 2024.

Wexford Capital reported no remaining Firefly Neuroscience position as of Q4 2024 after selling out during the quarter.
Wexford Capital sold 961 Firefly Neuroscience shares in Q4 2024, an estimated $2.92K.
Wexford Capital first reported a position in Firefly Neuroscience in Q3 2024 and held it in 1 quarter.
Wexford Capital's Firefly Neuroscience position peaked at $2.92K in Q3 2024.
12 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q4 2024.

Based on Wexford Capital's 13F filing for Q4 2024, filed 14 Feb 2025.